SEARCH

SEARCH BY CITATION

References

  • Altman, J.D. & Moss, P.A.H. (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science, 274, 9496.DOI: 10.1126/science.274.5284.94
  • Boniface, J.J., Rabinowitz, J.D., Wulfing, C., Hample, J., Reich, Z., Altman, J.D., Kantor, R.M., Beessson, C., Mconnell, H.M., Davis, M.M. (1998) Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligand. Immunity, 9, 459891 .
  • Broers, A.E.C., Van Der Holt, R., Van Esser, J.W.J., Gratma, J.W., Henzen-Longmans, S., Kuenen-Boumeester, V., Lowenberg, B., Cornelissen, J.J. (2000) Increased transplant-related morbidity and mortality in CMV-antibody positive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood, 95, 22402252.
  • Couriel, D., Canosa, J., Engler, H., Collins, A., Dunbar, A., Barret, A.J. (1996) Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with haematological malignancies. Bone Marrow Transplantation, 18, 347353.
  • Craddock, C., Szydlo, R.M., Dazzi, F., Olavarria, E., Cwynarski, K., Yong, A., Brookes, P., De La Fuente, J., Kanfer, E., Apperley, J.F., Goldman, J.M. (2001) Cytomegalovirus seropositivity adversely influences outcome after, T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis. British Journal of Haematology, 112, 228236.DOI: 10.1046/j.1365-2141.2001.02519.x
  • Czerkinski, C., Anderson, G., Ekre, H.P., Nilson, L.A., Klareskog, M., Ouchterlony, O. (1988) Reverse Elispot assay for the clonal analysis of cytokine production. Journal of Immunological Methods, 110, 2936.
  • Gillespie, G.M., Wills, M.R., Appay, V., O'Callaghan, C., Murphy, M., Smith, N., Sissons, P., Rowland-Jones, S., Bell, J.I., Moss, P.A. (2000) Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8 (+) T lymphocytes in healthy antibody positive donors. Journal of Virology, 74, 81408150.
  • Maltazou, H., Whimbey, E., Abi-Said, D., Prezepiorka, D., Champlain, R., Goodrich, J. (1999) Cytomegalovirus disease in adult marrow transplant recipients receiving gangcyclovir prophylaxis: a retrospective study. Bone Marrow Transplantation, 24, 665669.
  • Osarogiagbon, R.U., Defor, T.E., Weisdorf, M.A., Erice, A., Weisdorf, D.J. (2000) CMV antigenemia following bone marrow transplantation: risk factors and outcomes. Biological Blood Marrow Transplantation, 6, 280288.
  • Podlech, J., Holtappels, R., Wirtz, N., Steffens, H.P., Reddehase, M.J. (1998) Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation. Journal of General Virology, 79, 20992104.
  • Radbruch A., Mechtold, B., Theil, A., Miltenyi, S., Pfluger, E. (1994) High gradient magnetic cell sorting. Methods in Cell Biology, 42, 387403.
  • Walter, E.A., Greenberg, P.D., Gilbert, M.J., Finch, R.J., Watanabe, K.S., Thomas, E.D., Ridell, S.R. (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. New England Journal of Medicine, 333, 10381044.
  • Wills, M.R., Carmichael, A.J., Mynard, K., Jin, X., Weekes, M.P., Plachter, B., Sissons, J.P.G. (1996) The human cytolytic T- lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein /pp. 65: frequency, specificityand T-cell receptor usage of /pp. 65-Specific CTL. Journal of Virology, 70, 75697579.
  • Witt, V., Freitsch, G., Peters, C., Matthes-Martin, S., Landenstein, R., Gadner, H. (1998) Resolution of earlt cytomegalovirus (CMV) infection after leukocyte transfusion therapy from a CMV antibody positive donor. Bone Marrow Transplantation, 22, 289292.